Reactivations of Cytomegalovirus, Human Herpes Virus 6, and Epstein-Barr Virus Differ with Respect to Risk Factors and Clinical Outcome after Hematopoietic Stem Cell Transplantation

被引:41
|
作者
Jaskula, E. [1 ]
Dlubek, D. [1 ,2 ]
Sedzimirska, M. [2 ]
Duda, D. [2 ]
Tarnowska, A. [2 ]
Lange, A. [1 ,2 ]
机构
[1] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland
[2] Natl Bone Marrow Donor Registry, Lower Silesian Ctr Cellular Transplantat, Wroclaw, Poland
关键词
ACUTE LIMBIC ENCEPHALITIS; PREEMPTIVE THERAPY; INFECTION; PCR; RECIPIENTS; DISEASE; FEATURES; ASSAY; LOAD;
D O I
10.1016/j.transproceed.2010.07.027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
One hundred two recipients of hematopoietic stem cell transplants (HSCTs) 45, from siblings and 57 from matched unrelated donors, were followed for cytomegalovirus (CMV), human herpes virus (HHV) 6, and Epstein-Barr Virus (EBV) reactivation by quantitative polymerase chain reaction in the context of immunologic reconstitution and posttransplantation complications. CMV, EBV, and HHV6 DNA copies (>100 copies/10(5) cells) were detected in 34%, 27%, and 26% of patients, respectively. The presence of 100 copies of EBV or CMV was associated with posttransplant complications: 29/66 versus 6/36 (P <.01) or 24/66 versus 4/36 (P =.01). CMV reactivation was more frequent among patients with acute graft-versus-host disease grade >= I: 17/35 versus 18/67 (P <.05). Older patient age of adults >16 year (2/16 versus 33/86; P <.05) and, to a lesser extent, CMV IgG positivity before HSCT (34/84 versus 1/10; P =.08) or an HLA-mismatched graft (9/16 versus 26/86; P =.08) constituted risk factors for CMV reactivation, which resulted in a higher rate of bacterial pneumonia (7/11 versus 28/91; P =.04). EBV reactivation risk was associated with donor EBV IgG seropositivity (28/84 versus 0/10; P =.03) and donor female gender (18/47 versus 10/55; P =.03). In contrast to EBV and CMV, EBV reactivation itself was associated with encephalitis (5/8 versus 23/94; P =.013), which was also seen as a trend among HHV6 reactivations (8/8 versus 46/94; P =.08). Multivariate analysis demonstrated that these factors play independent roles in the reactivation of the investigated herpes viruses.
引用
收藏
页码:3273 / 3276
页数:4
相关论文
共 50 条
  • [21] Risk factors and clinical outcome for Herpes Simplex Virus reactivation in patients after allogeneic hematopoietic stem cell transplantation
    Uhlin, M.
    Stikvoort, A.
    Sundin, M.
    Mattsson, J.
    Remberger, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S407 - S408
  • [22] Epstein-Barr Virus Infection and Lymphoproliferative Disorder After Hematopoietic Cell Transplantation
    Zhong, Yazhen
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2012, 16 (02) : 211 - 214
  • [23] Epstein-Barr virus lymphoproliferative disease after hematopoietic stem cell transplant
    Rouce, Rayne H.
    Louis, Chrystal U.
    Heslop, Helen E.
    CURRENT OPINION IN HEMATOLOGY, 2014, 21 (06) : 476 - 481
  • [24] HUMAN HERPES VIRUS 6 AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Greco, R.
    Lorentino, F.
    Crucitti, L.
    Vago, L.
    Stanghellini, M. T. Lupo
    Forcina, A.
    Giglio, F.
    Morelli, M.
    Levati, G.
    Orsini, A.
    Carbone, M. R.
    Valtolina, V.
    Noviello, M.
    Marktel, S.
    Assanelli, A.
    Carrabba, M.
    Marcatti, M.
    Peccatori, J.
    Bernardi, M.
    Bonini, C.
    Corti, C.
    Ciceri, F.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S333 - S334
  • [25] A Co-Reactivation Model of Cytomegalovirus and Epstein-Barr Virus after Allogeneic Hematopoietic Stem Cell Transplantation Was Constructed to Predict Mortality after Transplantation
    Ren, Jinhua
    Chen, Shaozhen
    Hu, Jianda
    Yang, Ting
    BLOOD, 2023, 142
  • [26] Cytokine Gene Polymorphisms and Epstein-Barr Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
    Lin, Ren
    Fan, Zhiping
    Zhao, Ke
    Jiang, Qianli
    Sun, Jing
    Liu, Qifa
    BLOOD, 2015, 126 (23)
  • [27] Monitoring of cytomegalovirus, Epstein-Barr virus and adenovirus infections in hematopoietic stem cell transplant recipients
    Seflek, Buket
    Gumus, Hatice Hale
    Cimentepe, Mehmet
    Kupeli, Serhan
    Yarkin, Fugen
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (02): : 432 - 440
  • [28] Significance of Epstein-Barr Virus DNA Quantitation in Donors of Hematopoietic Stem Cell Transplantation
    Jung, Seungwon
    Lim, Jihyang
    Cho, Byung Sik
    Chae, Hyojin
    Kim, Myungshin
    Kim, Yonggoo
    Han, Kyungja
    Lee, Jong Wook
    Min, Woo Sung
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2010, 30 (06): : 554 - 558
  • [29] Cytomegalovirus and Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation
    Tsao, Shu-Yi
    Chang, Kung-Chao
    Chen, Ya-Ping
    Yeh, Yu-Min
    Su, Wu-Chou
    Chen, Tsai-Yun
    ANNALS OF HEMATOLOGY, 2011, 90 (01) : 113 - 114